News from NORD

FDA Orphan Product Grants Are Available


 

The Office of Orphan Products Development (OOPD) at the Food and Drug Administration (FDA) has posted information for those interested in applying for orphan product development grants. These are grants to support the clinical development of products for use in rare diseases or conditions for which no current therapy exists or when the product being developed will be superior to existing treatments.

Recommended Reading

Survivors of childhood cancers at increased risk for autoimmune diseases
MDedge Pediatrics
Eczema associated with childhood speech disorder
MDedge Pediatrics
Judicious antibiotic use key in ambulatory settings
MDedge Pediatrics
High IgE linked to poor treatment outcomes in AD patients
MDedge Pediatrics
U.S congenital syphilis rates on the rise
MDedge Pediatrics
VIDEO: How to handle pregnancy and breast feeding in rheumatoid arthritis
MDedge Pediatrics
Progress toward measles elimination slows
MDedge Pediatrics
NORD Releases First-Ever State Progress Report for Rare Diseases
MDedge Pediatrics
NIH NCATS Seeks Input for Strategic Plan
MDedge Pediatrics
NCATS Pre-Clinical Programs Now Accepting Collaborative Proposals
MDedge Pediatrics